Infectious Coryza Vaccine is used to prevent infectious rhinitis in chickens caused by Avian bacillus paragallinarum. The method is subcutaneous injection on the back of the neck.
This report aims to provide a comprehensive presentation of the global market for Infectious Coryza Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Infectious Coryza Vaccine. This report contains market size and forecasts of Infectious Coryza Vaccine in global, including the following market information:
Global Infectious Coryza Vaccine Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global Infectious Coryza Vaccine Market Sales, 2018-2023, 2024-2030, (K Units)
Global top five Infectious Coryza Vaccine companies in 2022 (%)
The global Infectious Coryza Vaccine market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Monovalent Vaccine Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Infectious Coryza Vaccine include Zoetis, Merck, Boehringer Ingelheim, Ceva Sant? Animale, Qilu Animal Health Products Co., Ltd., Tianjin Ruipu Biotechnology Co., Ltd., Harbin Pharmaceutical Group, Plyco Bioengineering Co., Ltd. and Qingdao Yibang Biological Engineering Co., Ltd., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Infectious Coryza Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Infectious Coryza Vaccine Market, by Type, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Infectious Coryza Vaccine Market Segment Percentages, by Type, 2022 (%)
Monovalent Vaccine
Bivalent Vaccine
Trivalent Vaccine
Global Infectious Coryza Vaccine Market, by Application, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Infectious Coryza Vaccine Market Segment Percentages, by Application, 2022 (%)
Retail
Online Sale
Others
Global Infectious Coryza Vaccine Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Infectious Coryza Vaccine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Infectious Coryza Vaccine revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Infectious Coryza Vaccine revenues share in global market, 2022 (%)
Key companies Infectious Coryza Vaccine sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Infectious Coryza Vaccine sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Zoetis
Merck
Boehringer Ingelheim
Ceva Sant? Animale
Qilu Animal Health Products Co., Ltd.
Tianjin Ruipu Biotechnology Co., Ltd.
Harbin Pharmaceutical Group
Plyco Bioengineering Co., Ltd.
Qingdao Yibang Biological Engineering Co., Ltd.
Shandong Lvdu Biological Technology Co., Ltd.
Shandong Huahong Biological Engineering Co., Ltd.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Infectious Coryza Vaccine, market overview.
Chapter 2: Global Infectious Coryza Vaccine market size in revenue and volume.
Chapter 3: Detailed analysis of Infectious Coryza Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Infectious Coryza Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Infectious Coryza Vaccine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Infectious Coryza Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Infectious Coryza Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Infectious Coryza Vaccine Overall Market Size
2.1 Global Infectious Coryza Vaccine Market Size: 2022 VS 2030
2.2 Global Infectious Coryza Vaccine Revenue, Prospects & Forecasts: 2018-2030
2.3 Global Infectious Coryza Vaccine Sales: 2018-2030
3 Company Landscape
3.1 Top Infectious Coryza Vaccine Players in Global Market
3.2 Top Global Infectious Coryza Vaccine Companies Ranked by Revenue
3.3 Global Infectious Coryza Vaccine Revenue by Companies
3.4 Global Infectious Coryza Vaccine Sales by Companies
3.5 Global Infectious Coryza Vaccine Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Infectious Coryza Vaccine Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Infectious Coryza Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Infectious Coryza Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Infectious Coryza Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Infectious Coryza Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Infectious Coryza Vaccine Market Size Markets, 2022 & 2030
4.1.2 Monovalent Vaccine
4.1.3 Bivalent Vaccine
4.1.4 Trivalent Vaccine
4.2 By Type - Global Infectious Coryza Vaccine Revenue & Forecasts
4.2.1 By Type - Global Infectious Coryza Vaccine Revenue, 2018-2023
4.2.2 By Type - Global Infectious Coryza Vaccine Revenue, 2024-2030
4.2.3 By Type - Global Infectious Coryza Vaccine Revenue Market Share, 2018-2030
4.3 By Type - Global Infectious Coryza Vaccine Sales & Forecasts
4.3.1 By Type - Global Infectious Coryza Vaccine Sales, 2018-2023
4.3.2 By Type - Global Infectious Coryza Vaccine Sales, 2024-2030
4.3.3 By Type - Global Infectious Coryza Vaccine Sales Market Share, 2018-2030
4.4 By Type - Global Infectious Coryza Vaccine Price (Manufacturers Selling Prices), 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Infectious Coryza Vaccine Market Size, 2022 & 2030
5.1.2 Retail
5.1.3 Online Sale
5.1.4 Others
5.2 By Application - Global Infectious Coryza Vaccine Revenue & Forecasts
5.2.1 By Application - Global Infectious Coryza Vaccine Revenue, 2018-2023
5.2.2 By Application - Global Infectious Coryza Vaccine Revenue, 2024-2030
5.2.3 By Application - Global Infectious Coryza Vaccine Revenue Market Share, 2018-2030
5.3 By Application - Global Infectious Coryza Vaccine Sales & Forecasts
5.3.1 By Application - Global Infectious Coryza Vaccine Sales, 2018-2023
5.3.2 By Application - Global Infectious Coryza Vaccine Sales, 2024-2030
5.3.3 By Application - Global Infectious Coryza Vaccine Sales Market Share, 2018-2030
5.4 By Application - Global Infectious Coryza Vaccine Price (Manufacturers Selling Prices), 2018-2030
6 Sights by Region
6.1 By Region - Global Infectious Coryza Vaccine Market Size, 2022 & 2030
6.2 By Region - Global Infectious Coryza Vaccine Revenue & Forecasts
6.2.1 By Region - Global Infectious Coryza Vaccine Revenue, 2018-2023
6.2.2 By Region - Global Infectious Coryza Vaccine Revenue, 2024-2030
6.2.3 By Region - Global Infectious Coryza Vaccine Revenue Market Share, 2018-2030
6.3 By Region - Global Infectious Coryza Vaccine Sales & Forecasts
6.3.1 By Region - Global Infectious Coryza Vaccine Sales, 2018-2023
6.3.2 By Region - Global Infectious Coryza Vaccine Sales, 2024-2030
6.3.3 By Region - Global Infectious Coryza Vaccine Sales Market Share, 2018-2030
6.4 North America
6.4.1 By Country - North America Infectious Coryza Vaccine Revenue, 2018-2030
6.4.2 By Country - North America Infectious Coryza Vaccine Sales, 2018-2030
6.4.3 US Infectious Coryza Vaccine Market Size, 2018-2030
6.4.4 Canada Infectious Coryza Vaccine Market Size, 2018-2030
6.4.5 Mexico Infectious Coryza Vaccine Market Size, 2018-2030
6.5 Europe
6.5.1 By Country - Europe Infectious Coryza Vaccine Revenue, 2018-2030
6.5.2 By Country - Europe Infectious Coryza Vaccine Sales, 2018-2030
6.5.3 Germany Infectious Coryza Vaccine Market Size, 2018-2030
6.5.4 France Infectious Coryza Vaccine Market Size, 2018-2030
6.5.5 U.K. Infectious Coryza Vaccine Market Size, 2018-2030
6.5.6 Italy Infectious Coryza Vaccine Market Size, 2018-2030
6.5.7 Russia Infectious Coryza Vaccine Market Size, 2018-2030
6.5.8 Nordic Countries Infectious Coryza Vaccine Market Size, 2018-2030
6.5.9 Benelux Infectious Coryza Vaccine Market Size, 2018-2030
6.6 Asia
6.6.1 By Region - Asia Infectious Coryza Vaccine Revenue, 2018-2030
6.6.2 By Region - Asia Infectious Coryza Vaccine Sales, 2018-2030
6.6.3 China Infectious Coryza Vaccine Market Size, 2018-2030
6.6.4 Japan Infectious Coryza Vaccine Market Size, 2018-2030
6.6.5 South Korea Infectious Coryza Vaccine Market Size, 2018-2030
6.6.6 Southeast Asia Infectious Coryza Vaccine Market Size, 2018-2030
6.6.7 India Infectious Coryza Vaccine Market Size, 2018-2030
6.7 South America
6.7.1 By Country - South America Infectious Coryza Vaccine Revenue, 2018-2030
6.7.2 By Country - South America Infectious Coryza Vaccine Sales, 2018-2030
6.7.3 Brazil Infectious Coryza Vaccine Market Size, 2018-2030
6.7.4 Argentina Infectious Coryza Vaccine Market Size, 2018-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Infectious Coryza Vaccine Revenue, 2018-2030
6.8.2 By Country - Middle East & Africa Infectious Coryza Vaccine Sales, 2018-2030
6.8.3 Turkey Infectious Coryza Vaccine Market Size, 2018-2030
6.8.4 Israel Infectious Coryza Vaccine Market Size, 2018-2030
6.8.5 Saudi Arabia Infectious Coryza Vaccine Market Size, 2018-2030
6.8.6 UAE Infectious Coryza Vaccine Market Size, 2018-2030
7 Manufacturers & Brands Profiles
7.1 Zoetis
7.1.1 Zoetis Company Summary
7.1.2 Zoetis Business Overview
7.1.3 Zoetis Infectious Coryza Vaccine Major Product Offerings
7.1.4 Zoetis Infectious Coryza Vaccine Sales and Revenue in Global (2018-2023)
7.1.5 Zoetis Key News & Latest Developments
7.2 Merck
7.2.1 Merck Company Summary
7.2.2 Merck Business Overview
7.2.3 Merck Infectious Coryza Vaccine Major Product Offerings
7.2.4 Merck Infectious Coryza Vaccine Sales and Revenue in Global (2018-2023)
7.2.5 Merck Key News & Latest Developments
7.3 Boehringer Ingelheim
7.3.1 Boehringer Ingelheim Company Summary
7.3.2 Boehringer Ingelheim Business Overview
7.3.3 Boehringer Ingelheim Infectious Coryza Vaccine Major Product Offerings
7.3.4 Boehringer Ingelheim Infectious Coryza Vaccine Sales and Revenue in Global (2018-2023)
7.3.5 Boehringer Ingelheim Key News & Latest Developments
7.4 Ceva Sant? Animale
7.4.1 Ceva Sant? Animale Company Summary
7.4.2 Ceva Sant? Animale Business Overview
7.4.3 Ceva Sant? Animale Infectious Coryza Vaccine Major Product Offerings
7.4.4 Ceva Sant? Animale Infectious Coryza Vaccine Sales and Revenue in Global (2018-2023)
7.4.5 Ceva Sant? Animale Key News & Latest Developments
7.5 Qilu Animal Health Products Co., Ltd.
7.5.1 Qilu Animal Health Products Co., Ltd. Company Summary
7.5.2 Qilu Animal Health Products Co., Ltd. Business Overview
7.5.3 Qilu Animal Health Products Co., Ltd. Infectious Coryza Vaccine Major Product Offerings
7.5.4 Qilu Animal Health Products Co., Ltd. Infectious Coryza Vaccine Sales and Revenue in Global (2018-2023)
7.5.5 Qilu Animal Health Products Co., Ltd. Key News & Latest Developments
7.6 Tianjin Ruipu Biotechnology Co., Ltd.
7.6.1 Tianjin Ruipu Biotechnology Co., Ltd. Company Summary
7.6.2 Tianjin Ruipu Biotechnology Co., Ltd. Business Overview
7.6.3 Tianjin Ruipu Biotechnology Co., Ltd. Infectious Coryza Vaccine Major Product Offerings
7.6.4 Tianjin Ruipu Biotechnology Co., Ltd. Infectious Coryza Vaccine Sales and Revenue in Global (2018-2023)
7.6.5 Tianjin Ruipu Biotechnology Co., Ltd. Key News & Latest Developments
7.7 Harbin Pharmaceutical Group
7.7.1 Harbin Pharmaceutical Group Company Summary
7.7.2 Harbin Pharmaceutical Group Business Overview
7.7.3 Harbin Pharmaceutical Group Infectious Coryza Vaccine Major Product Offerings
7.7.4 Harbin Pharmaceutical Group Infectious Coryza Vaccine Sales and Revenue in Global (2018-2023)
7.7.5 Harbin Pharmaceutical Group Key News & Latest Developments
7.8 Plyco Bioengineering Co., Ltd.
7.8.1 Plyco Bioengineering Co., Ltd. Company Summary
7.8.2 Plyco Bioengineering Co., Ltd. Business Overview
7.8.3 Plyco Bioengineering Co., Ltd. Infectious Coryza Vaccine Major Product Offerings
7.8.4 Plyco Bioengineering Co., Ltd. Infectious Coryza Vaccine Sales and Revenue in Global (2018-2023)
7.8.5 Plyco Bioengineering Co., Ltd. Key News & Latest Developments
7.9 Qingdao Yibang Biological Engineering Co., Ltd.
7.9.1 Qingdao Yibang Biological Engineering Co., Ltd. Company Summary
7.9.2 Qingdao Yibang Biological Engineering Co., Ltd. Business Overview
7.9.3 Qingdao Yibang Biological Engineering Co., Ltd. Infectious Coryza Vaccine Major Product Offerings
7.9.4 Qingdao Yibang Biological Engineering Co., Ltd. Infectious Coryza Vaccine Sales and Revenue in Global (2018-2023)
7.9.5 Qingdao Yibang Biological Engineering Co., Ltd. Key News & Latest Developments
7.10 Shandong Lvdu Biological Technology Co., Ltd.
7.10.1 Shandong Lvdu Biological Technology Co., Ltd. Company Summary
7.10.2 Shandong Lvdu Biological Technology Co., Ltd. Business Overview
7.10.3 Shandong Lvdu Biological Technology Co., Ltd. Infectious Coryza Vaccine Major Product Offerings
7.10.4 Shandong Lvdu Biological Technology Co., Ltd. Infectious Coryza Vaccine Sales and Revenue in Global (2018-2023)
7.10.5 Shandong Lvdu Biological Technology Co., Ltd. Key News & Latest Developments
7.11 Shandong Huahong Biological Engineering Co., Ltd.
7.11.1 Shandong Huahong Biological Engineering Co., Ltd. Company Summary
7.11.2 Shandong Huahong Biological Engineering Co., Ltd. Infectious Coryza Vaccine Business Overview
7.11.3 Shandong Huahong Biological Engineering Co., Ltd. Infectious Coryza Vaccine Major Product Offerings
7.11.4 Shandong Huahong Biological Engineering Co., Ltd. Infectious Coryza Vaccine Sales and Revenue in Global (2018-2023)
7.11.5 Shandong Huahong Biological Engineering Co., Ltd. Key News & Latest Developments
8 Global Infectious Coryza Vaccine Production Capacity, Analysis
8.1 Global Infectious Coryza Vaccine Production Capacity, 2018-2030
8.2 Infectious Coryza Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Infectious Coryza Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Infectious Coryza Vaccine Supply Chain Analysis
10.1 Infectious Coryza Vaccine Industry Value Chain
10.2 Infectious Coryza Vaccine Upstream Market
10.3 Infectious Coryza Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Infectious Coryza Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Infectious Coryza Vaccine in Global Market
Table 2. Top Infectious Coryza Vaccine Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Infectious Coryza Vaccine Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Infectious Coryza Vaccine Revenue Share by Companies, 2018-2023
Table 5. Global Infectious Coryza Vaccine Sales by Companies, (K Units), 2018-2023
Table 6. Global Infectious Coryza Vaccine Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Infectious Coryza Vaccine Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Infectious Coryza Vaccine Product Type
Table 9. List of Global Tier 1 Infectious Coryza Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Infectious Coryza Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Infectious Coryza Vaccine Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Global Infectious Coryza Vaccine Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Infectious Coryza Vaccine Revenue (US$, Mn), 2024-2030
Table 14. By Type - Global Infectious Coryza Vaccine Sales (K Units), 2018-2023
Table 15. By Type - Global Infectious Coryza Vaccine Sales (K Units), 2024-2030
Table 16. By Application ? Global Infectious Coryza Vaccine Revenue, (US$, Mn), 2022 & 2030
Table 17. By Application - Global Infectious Coryza Vaccine Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Infectious Coryza Vaccine Revenue (US$, Mn), 2024-2030
Table 19. By Application - Global Infectious Coryza Vaccine Sales (K Units), 2018-2023
Table 20. By Application - Global Infectious Coryza Vaccine Sales (K Units), 2024-2030
Table 21. By Region ? Global Infectious Coryza Vaccine Revenue, (US$, Mn), 2022 VS 2030
Table 22. By Region - Global Infectious Coryza Vaccine Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Infectious Coryza Vaccine Revenue (US$, Mn), 2024-2030
Table 24. By Region - Global Infectious Coryza Vaccine Sales (K Units), 2018-2023
Table 25. By Region - Global Infectious Coryza Vaccine Sales (K Units), 2024-2030
Table 26. By Country - North America Infectious Coryza Vaccine Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Infectious Coryza Vaccine Revenue, (US$, Mn), 2024-2030
Table 28. By Country - North America Infectious Coryza Vaccine Sales, (K Units), 2018-2023
Table 29. By Country - North America Infectious Coryza Vaccine Sales, (K Units), 2024-2030
Table 30. By Country - Europe Infectious Coryza Vaccine Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Infectious Coryza Vaccine Revenue, (US$, Mn), 2024-2030
Table 32. By Country - Europe Infectious Coryza Vaccine Sales, (K Units), 2018-2023
Table 33. By Country - Europe Infectious Coryza Vaccine Sales, (K Units), 2024-2030
Table 34. By Region - Asia Infectious Coryza Vaccine Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Infectious Coryza Vaccine Revenue, (US$, Mn), 2024-2030
Table 36. By Region - Asia Infectious Coryza Vaccine Sales, (K Units), 2018-2023
Table 37. By Region - Asia Infectious Coryza Vaccine Sales, (K Units), 2024-2030
Table 38. By Country - South America Infectious Coryza Vaccine Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Infectious Coryza Vaccine Revenue, (US$, Mn), 2024-2030
Table 40. By Country - South America Infectious Coryza Vaccine Sales, (K Units), 2018-2023
Table 41. By Country - South America Infectious Coryza Vaccine Sales, (K Units), 2024-2030
Table 42. By Country - Middle East & Africa Infectious Coryza Vaccine Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Infectious Coryza Vaccine Revenue, (US$, Mn), 2024-2030
Table 44. By Country - Middle East & Africa Infectious Coryza Vaccine Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Infectious Coryza Vaccine Sales, (K Units), 2024-2030
Table 46. Zoetis Company Summary
Table 47. Zoetis Infectious Coryza Vaccine Product Offerings
Table 48. Zoetis Infectious Coryza Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Zoetis Key News & Latest Developments
Table 50. Merck Company Summary
Table 51. Merck Infectious Coryza Vaccine Product Offerings
Table 52. Merck Infectious Coryza Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Merck Key News & Latest Developments
Table 54. Boehringer Ingelheim Company Summary
Table 55. Boehringer Ingelheim Infectious Coryza Vaccine Product Offerings
Table 56. Boehringer Ingelheim Infectious Coryza Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Boehringer Ingelheim Key News & Latest Developments
Table 58. Ceva Sant? Animale Company Summary
Table 59. Ceva Sant? Animale Infectious Coryza Vaccine Product Offerings
Table 60. Ceva Sant? Animale Infectious Coryza Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Ceva Sant? Animale Key News & Latest Developments
Table 62. Qilu Animal Health Products Co., Ltd. Company Summary
Table 63. Qilu Animal Health Products Co., Ltd. Infectious Coryza Vaccine Product Offerings
Table 64. Qilu Animal Health Products Co., Ltd. Infectious Coryza Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Qilu Animal Health Products Co., Ltd. Key News & Latest Developments
Table 66. Tianjin Ruipu Biotechnology Co., Ltd. Company Summary
Table 67. Tianjin Ruipu Biotechnology Co., Ltd. Infectious Coryza Vaccine Product Offerings
Table 68. Tianjin Ruipu Biotechnology Co., Ltd. Infectious Coryza Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Tianjin Ruipu Biotechnology Co., Ltd. Key News & Latest Developments
Table 70. Harbin Pharmaceutical Group Company Summary
Table 71. Harbin Pharmaceutical Group Infectious Coryza Vaccine Product Offerings
Table 72. Harbin Pharmaceutical Group Infectious Coryza Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Harbin Pharmaceutical Group Key News & Latest Developments
Table 74. Plyco Bioengineering Co., Ltd. Company Summary
Table 75. Plyco Bioengineering Co., Ltd. Infectious Coryza Vaccine Product Offerings
Table 76. Plyco Bioengineering Co., Ltd. Infectious Coryza Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Plyco Bioengineering Co., Ltd. Key News & Latest Developments
Table 78. Qingdao Yibang Biological Engineering Co., Ltd. Company Summary
Table 79. Qingdao Yibang Biological Engineering Co., Ltd. Infectious Coryza Vaccine Product Offerings
Table 80. Qingdao Yibang Biological Engineering Co., Ltd. Infectious Coryza Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Qingdao Yibang Biological Engineering Co., Ltd. Key News & Latest Developments
Table 82. Shandong Lvdu Biological Technology Co., Ltd. Company Summary
Table 83. Shandong Lvdu Biological Technology Co., Ltd. Infectious Coryza Vaccine Product Offerings
Table 84. Shandong Lvdu Biological Technology Co., Ltd. Infectious Coryza Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Shandong Lvdu Biological Technology Co., Ltd. Key News & Latest Developments
Table 86. Shandong Huahong Biological Engineering Co., Ltd. Company Summary
Table 87. Shandong Huahong Biological Engineering Co., Ltd. Infectious Coryza Vaccine Product Offerings
Table 88. Shandong Huahong Biological Engineering Co., Ltd. Infectious Coryza Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. Shandong Huahong Biological Engineering Co., Ltd. Key News & Latest Developments
Table 90. Infectious Coryza Vaccine Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 91. Global Infectious Coryza Vaccine Capacity Market Share of Key Manufacturers, 2021-2023
Table 92. Global Infectious Coryza Vaccine Production by Region, 2018-2023 (K Units)
Table 93. Global Infectious Coryza Vaccine Production by Region, 2024-2030 (K Units)
Table 94. Infectious Coryza Vaccine Market Opportunities & Trends in Global Market
Table 95. Infectious Coryza Vaccine Market Drivers in Global Market
Table 96. Infectious Coryza Vaccine Market Restraints in Global Market
Table 97. Infectious Coryza Vaccine Raw Materials
Table 98. Infectious Coryza Vaccine Raw Materials Suppliers in Global Market
Table 99. Typical Infectious Coryza Vaccine Downstream
Table 100. Infectious Coryza Vaccine Downstream Clients in Global Market
Table 101. Infectious Coryza Vaccine Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Infectious Coryza Vaccine Segment by Type in 2022
Figure 2. Infectious Coryza Vaccine Segment by Application in 2022
Figure 3. Global Infectious Coryza Vaccine Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Infectious Coryza Vaccine Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Infectious Coryza Vaccine Revenue, 2018-2030 (US$, Mn)
Figure 7. Infectious Coryza Vaccine Sales in Global Market: 2018-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Infectious Coryza Vaccine Revenue in 2022
Figure 9. By Type - Global Infectious Coryza Vaccine Revenue, (US$, Mn), 2022 & 2030
Figure 10. By Type - Global Infectious Coryza Vaccine Revenue Market Share, 2018-2030
Figure 11. By Type - Global Infectious Coryza Vaccine Sales Market Share, 2018-2030
Figure 12. By Type - Global Infectious Coryza Vaccine Price (US$/Unit), 2018-2030
Figure 13. By Application - Global Infectious Coryza Vaccine Revenue, (US$, Mn), 2022 & 2030
Figure 14. By Application - Global Infectious Coryza Vaccine Revenue Market Share, 2018-2030
Figure 15. By Application - Global Infectious Coryza Vaccine Sales Market Share, 2018-2030
Figure 16. By Application - Global Infectious Coryza Vaccine Price (US$/Unit), 2018-2030
Figure 17. By Region - Global Infectious Coryza Vaccine Revenue, (US$, Mn), 2022 & 2030
Figure 18. By Region - Global Infectious Coryza Vaccine Revenue Market Share, 2018 VS 2022 VS 2030
Figure 19. By Region - Global Infectious Coryza Vaccine Revenue Market Share, 2018-2030
Figure 20. By Region - Global Infectious Coryza Vaccine Sales Market Share, 2018-2030
Figure 21. By Country - North America Infectious Coryza Vaccine Revenue Market Share, 2018-2030
Figure 22. By Country - North America Infectious Coryza Vaccine Sales Market Share, 2018-2030
Figure 23. US Infectious Coryza Vaccine Revenue, (US$, Mn), 2018-2030
Figure 24. Canada Infectious Coryza Vaccine Revenue, (US$, Mn), 2018-2030
Figure 25. Mexico Infectious Coryza Vaccine Revenue, (US$, Mn), 2018-2030
Figure 26. By Country - Europe Infectious Coryza Vaccine Revenue Market Share, 2018-2030
Figure 27. By Country - Europe Infectious Coryza Vaccine Sales Market Share, 2018-2030
Figure 28. Germany Infectious Coryza Vaccine Revenue, (US$, Mn), 2018-2030
Figure 29. France Infectious Coryza Vaccine Revenue, (US$, Mn), 2018-2030
Figure 30. U.K. Infectious Coryza Vaccine Revenue, (US$, Mn), 2018-2030
Figure 31. Italy Infectious Coryza Vaccine Revenue, (US$, Mn), 2018-2030
Figure 32. Russia Infectious Coryza Vaccine Revenue, (US$, Mn), 2018-2030
Figure 33. Nordic Countries Infectious Coryza Vaccine Revenue, (US$, Mn), 2018-2030
Figure 34. Benelux Infectious Coryza Vaccine Revenue, (US$, Mn), 2018-2030
Figure 35. By Region - Asia Infectious Coryza Vaccine Revenue Market Share, 2018-2030
Figure 36. By Region - Asia Infectious Coryza Vaccine Sales Market Share, 2018-2030
Figure 37. China Infectious Coryza Vaccine Revenue, (US$, Mn), 2018-2030
Figure 38. Japan Infectious Coryza Vaccine Revenue, (US$, Mn), 2018-2030
Figure 39. South Korea Infectious Coryza Vaccine Revenue, (US$, Mn), 2018-2030
Figure 40. Southeast Asia Infectious Coryza Vaccine Revenue, (US$, Mn), 2018-2030
Figure 41. India Infectious Coryza Vaccine Revenue, (US$, Mn), 2018-2030
Figure 42. By Country - South America Infectious Coryza Vaccine Revenue Market Share, 2018-2030
Figure 43. By Country - South America Infectious Coryza Vaccine Sales Market Share, 2018-2030
Figure 44. Brazil Infectious Coryza Vaccine Revenue, (US$, Mn), 2018-2030
Figure 45. Argentina Infectious Coryza Vaccine Revenue, (US$, Mn), 2018-2030
Figure 46. By Country - Middle East & Africa Infectious Coryza Vaccine Revenue Market Share, 2018-2030
Figure 47. By Country - Middle East & Africa Infectious Coryza Vaccine Sales Market Share, 2018-2030
Figure 48. Turkey Infectious Coryza Vaccine Revenue, (US$, Mn), 2018-2030
Figure 49. Israel Infectious Coryza Vaccine Revenue, (US$, Mn), 2018-2030
Figure 50. Saudi Arabia Infectious Coryza Vaccine Revenue, (US$, Mn), 2018-2030
Figure 51. UAE Infectious Coryza Vaccine Revenue, (US$, Mn), 2018-2030
Figure 52. Global Infectious Coryza Vaccine Production Capacity (K Units), 2018-2030
Figure 53. The Percentage of Production Infectious Coryza Vaccine by Region, 2022 VS 2030
Figure 54. Infectious Coryza Vaccine Industry Value Chain
Figure 55. Marketing Channels
